185 related articles for article (PubMed ID: 17806115)
1. Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization.
Nakamura S; Nambu M; Ishizuka T; Hattori H; Kanatani Y; Takase B; Kishimoto S; Amano Y; Aoki H; Kiyosawa T; Ishihara M; Maehara T
J Biomed Mater Res A; 2008 Jun; 85(3):619-27. PubMed ID: 17806115
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model.
Fujita M; Ishihara M; Shimizu M; Obara K; Nakamura S; Kanatani Y; Morimoto Y; Takase B; Matsui T; Kikuchi M; Maehara T
Wound Repair Regen; 2007; 15(1):58-65. PubMed ID: 17244320
[TBL] [Abstract][Full Text] [Related]
3. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization.
Ishihara M; Obara K; Ishizuka T; Fujita M; Sato M; Masuoka K; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A
J Biomed Mater Res A; 2003 Mar; 64(3):551-9. PubMed ID: 12579570
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularization.
Nakamura S; Ishihara M; Obara K; Masuoka K; Ishizuka T; Kanatani Y; Takase B; Matsui T; Hattori H; Sato T; Kariya Y; Maehara T
J Biomed Mater Res A; 2006 Aug; 78(2):364-71. PubMed ID: 16673389
[TBL] [Abstract][Full Text] [Related]
5. The interaction of chitosan with fibroblast growth factor-2 and its protection from inactivation.
Masuoka K; Ishihara M; Asazuma T; Hattori H; Matsui T; Takase B; Kanatani Y; Fujita M; Saito Y; Yura H; Fujikawa K; Nemoto K
Biomaterials; 2005 Jun; 26(16):3277-84. PubMed ID: 15603823
[TBL] [Abstract][Full Text] [Related]
6. Controlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularization.
Nakamura S; Kanatani Y; Kishimoto S; Nakamura S; Ohno C; Horio T; Masanori F; Hattori H; Tanaka Y; Kiyosawa T; Maehara T; Ishihara M
J Biomed Mater Res A; 2009 Dec; 91(3):814-23. PubMed ID: 19051304
[TBL] [Abstract][Full Text] [Related]
7. Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel.
Fujita M; Ishihara M; Simizu M; Obara K; Ishizuka T; Saito Y; Yura H; Morimoto Y; Takase B; Matsui T; Kikuchi M; Maehara T
Biomaterials; 2004 Feb; 25(4):699-706. PubMed ID: 14607508
[TBL] [Abstract][Full Text] [Related]
8. Acceleration of wound healing in healing-impaired db/db mice with a photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2.
Obara K; Ishihara M; Fujita M; Kanatani Y; Hattori H; Matsui T; Takase B; Ozeki Y; Nakamura S; Ishizuka T; Tominaga S; Hiroi S; Kawai T; Maehara T
Wound Repair Regen; 2005; 13(4):390-7. PubMed ID: 16008728
[TBL] [Abstract][Full Text] [Related]
9. Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice.
Obara K; Ishihara M; Ozeki Y; Ishizuka T; Hayashi T; Nakamura S; Saito Y; Yura H; Matsui T; Hattori H; Takase B; Ishihara M; Kikuchi M; Maehara T
J Control Release; 2005 Dec; 110(1):79-89. PubMed ID: 16289419
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 in a rabbit model of chronic myocardial infarction.
Fujita M; Ishihara M; Morimoto Y; Simizu M; Saito Y; Yura H; Matsui T; Takase B; Hattori H; Kanatani Y; Kikuchi M; Maehara T
J Surg Res; 2005 Jun; 126(1):27-33. PubMed ID: 15916971
[TBL] [Abstract][Full Text] [Related]
11. Controlled releases of FGF-2 and paclitaxel from chitosan hydrogels and their subsequent effects on wound repair, angiogenesis, and tumor growth.
Ishihara M; Fujita M; Obara K; Hattori H; Nakamura S; Nambu M; Kiyosawa T; Kanatani Y; Takase B; Kikuchi M; Maehara T
Curr Drug Deliv; 2006 Oct; 3(4):351-8. PubMed ID: 17076636
[TBL] [Abstract][Full Text] [Related]
12. Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration.
Hosseinkhani H; Hosseinkhani M; Khademhosseini A; Kobayashi H; Tabata Y
Biomaterials; 2006 Dec; 27(34):5836-44. PubMed ID: 16930687
[TBL] [Abstract][Full Text] [Related]
13. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
Cai S; Liu Y; Zheng Shu X; Prestwich GD
Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of FGF-2 and G-CSF from gelatin-based hydrogels as angiogenic therapy in a murine critical limb ischemic model.
Layman H; Sacasa M; Murphy AE; Murphy AM; Pham SM; Andreopoulos FM
Acta Biomater; 2009 Jan; 5(1):230-9. PubMed ID: 18713669
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of functional chitosan thermosensitive hydrogel for slow release both rhBMP-2 and chlorhexidine].
Ma ZW; Wang R; Wu ZF; Chen D; Zhang BL; He W; Wang XJ; Liu Q; Xu J; Zhu H
Sheng Wu Gong Cheng Xue Bao; 2007 Nov; 23(6):1049-54. PubMed ID: 18257235
[TBL] [Abstract][Full Text] [Related]
16. Vascularization around poly(tetrafluoroethylene) mesh with coating of gelatin hydrogel incorporating basic fibroblast growth factor.
Takaoka R; Hikasa Y; Tabata Y
J Biomater Sci Polym Ed; 2009; 20(10):1483-94. PubMed ID: 19622284
[TBL] [Abstract][Full Text] [Related]
17. Novel functional biodegradable polymer IV: pH-sensitive controlled release of fibroblast growth factor-2 from a poly(gamma-glutamic acid)-sulfonate matrix for tissue engineering.
Matsusaki M; Akashi M
Biomacromolecules; 2005; 6(6):3351-6. PubMed ID: 16283765
[TBL] [Abstract][Full Text] [Related]
18. Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor.
Ho YC; Mi FL; Sung HW; Kuo PL
Int J Pharm; 2009 Jul; 376(1-2):69-75. PubMed ID: 19450670
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight fucoidan promotes therapeutic revascularization in a rat model of critical hindlimb ischemia.
Luyt CE; Meddahi-Pellé A; Ho-Tin-Noe B; Colliec-Jouault S; Guezennec J; Louedec L; Prats H; Jacob MP; Osborne-Pellegrin M; Letourneur D; Michel JB
J Pharmacol Exp Ther; 2003 Apr; 305(1):24-30. PubMed ID: 12649349
[TBL] [Abstract][Full Text] [Related]
20. The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model.
Ruvinov E; Leor J; Cohen S
Biomaterials; 2010 Jun; 31(16):4573-82. PubMed ID: 20206988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
